DE69333108D1 - Benzodiazepin derivate verwendbar als cck-rezeptoren antagonisten - Google Patents

Benzodiazepin derivate verwendbar als cck-rezeptoren antagonisten

Info

Publication number
DE69333108D1
DE69333108D1 DE69333108T DE69333108T DE69333108D1 DE 69333108 D1 DE69333108 D1 DE 69333108D1 DE 69333108 T DE69333108 T DE 69333108T DE 69333108 T DE69333108 T DE 69333108T DE 69333108 D1 DE69333108 D1 DE 69333108D1
Authority
DE
Germany
Prior art keywords
benzodiazepine derivatives
pct
receptor antagonists
derivatives used
cck receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333108T
Other languages
English (en)
Other versions
DE69333108T2 (de
Inventor
Hamish Ryder
Graeme Semple
Alan Kendrick
Michael Szelke
Masato Satoh
Mitsuaki Ohta
Keiji Miyata
Akito Nishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring Research Ltd
Astellas Pharma Inc
Original Assignee
Ferring Research Ltd
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9204221A external-priority patent/GB2264492B/en
Application filed by Ferring Research Ltd, Yamanouchi Pharmaceutical Co Ltd filed Critical Ferring Research Ltd
Application granted granted Critical
Publication of DE69333108D1 publication Critical patent/DE69333108D1/de
Publication of DE69333108T2 publication Critical patent/DE69333108T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69333108T 1992-02-27 1993-02-26 Benzodiazepin derivate verwendbar als cck-rezeptoren antagonisten Expired - Fee Related DE69333108T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9204221 1992-02-27
GB9204221A GB2264492B (en) 1992-02-27 1992-02-27 Benzodiazepine derivatives
GB929212740A GB9212740D0 (en) 1992-02-27 1992-06-16 Benzodiazephine derivatives
GB9212740 1992-06-16
PCT/GB1993/000404 WO1993016999A1 (en) 1992-02-27 1993-02-26 Benzodiazepin derivatives useful as cck-receptor antagonists

Publications (2)

Publication Number Publication Date
DE69333108D1 true DE69333108D1 (de) 2003-08-28
DE69333108T2 DE69333108T2 (de) 2004-04-15

Family

ID=26300386

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333108T Expired - Fee Related DE69333108T2 (de) 1992-02-27 1993-02-26 Benzodiazepin derivate verwendbar als cck-rezeptoren antagonisten

Country Status (18)

Country Link
US (2) US5688943A (de)
EP (1) EP0628033B1 (de)
JP (1) JP2571344B2 (de)
CN (1) CN1051079C (de)
AT (1) ATE245632T1 (de)
AU (1) AU672390B2 (de)
CA (1) CA2129990C (de)
DE (1) DE69333108T2 (de)
DK (1) DK0628033T3 (de)
ES (1) ES2203616T3 (de)
FI (1) FI121234B (de)
HU (1) HU224012B1 (de)
IL (1) IL104853A (de)
NO (1) NO311215B1 (de)
PT (1) PT628033E (de)
RU (1) RU2139282C1 (de)
TW (1) TW438783B (de)
WO (1) WO1993016999A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539170A1 (de) * 1991-10-24 1993-04-28 Merck Sharp & Dohme Ltd. Benzodiazepinderivate und ihre Verwendung als Antagonisten von Cholecystokinin und/oder Gastrin-Rezeptoren
GB2282595A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
GB2282594A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
US5556969A (en) * 1994-12-07 1996-09-17 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives
AUPO284396A0 (en) * 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US6100254A (en) * 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
EP1391203A4 (de) * 2001-05-11 2005-09-14 Astellas Pharma Inc Antitumorale mittel
WO2004101533A1 (en) * 2003-05-12 2004-11-25 Janssen Pharmaceutica, N.V. 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
US8053413B2 (en) * 2005-06-06 2011-11-08 The Board Of Trustees Of The University Of Illinois Methods for treating sleep disorders by cholecystokinin (CCK) receptor B antagonists
CN101669557B (zh) * 2009-08-20 2012-07-25 杭州六易科技有限公司 一种清热解毒凉茶的制作方法
KR101435729B1 (ko) * 2009-09-28 2014-09-01 닛뽕소다 가부시키가이샤 함질소 헤테로 고리 화합물 및 그의 염, 그리고 농원예용 살균제
PL3071206T3 (pl) 2013-11-22 2022-01-17 CL BioSciences LLC Antagoniści gastryny (eg yf476, netazepid) do leczenia i zapobiegania osteoporozie
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
CN110177565A (zh) * 2016-09-09 2019-08-27 目标实验室有限责任公司 胆囊收缩素2受体靶向近红外成像及其用途
US10881667B2 (en) * 2018-10-30 2021-01-05 City University Of Hong Kong Method and composition for treating epilepsy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
CA2026856A1 (en) * 1989-10-05 1991-04-06 Mark G. Bock 3-substituted-1,4-benzodiazepines useful as oxytocin
CA2032226A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
IE904560A1 (en) * 1989-12-18 1991-06-19 Merck & Co Inc New benzodiazepine analogs
US4994258A (en) * 1990-03-05 1991-02-19 Merck & Co., Inc. Gamma emitting, CCK-A antagonists for pancreatic imaging
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
US5218115A (en) * 1991-04-10 1993-06-08 Merck & Co., Inc. Cholecystokinin antagonists
US5218114A (en) * 1991-04-10 1993-06-08 Merck & Co., Inc. Cholecystokinin antagonists

Also Published As

Publication number Publication date
IL104853A (en) 1997-11-20
US5688943A (en) 1997-11-18
FI943941A (fi) 1994-10-26
DE69333108T2 (de) 2004-04-15
FI121234B (fi) 2010-08-31
FI943941A0 (fi) 1994-08-26
HU224012B1 (hu) 2005-04-28
AU3639193A (en) 1993-09-13
EP0628033A1 (de) 1994-12-14
NO311215B1 (no) 2001-10-29
TW438783B (en) 2001-06-07
AU672390B2 (en) 1996-10-03
RU2139282C1 (ru) 1999-10-10
ES2203616T3 (es) 2004-04-16
NO943133L (no) 1994-08-24
PT628033E (pt) 2003-12-31
HUT67963A (en) 1995-05-29
HU9402212D0 (en) 1994-09-28
RU94038255A (ru) 1996-07-10
CN1075717A (zh) 1993-09-01
JPH07505121A (ja) 1995-06-08
IL104853A0 (en) 1993-06-10
ATE245632T1 (de) 2003-08-15
EP0628033B1 (de) 2003-07-23
WO1993016999A1 (en) 1993-09-02
US5962451A (en) 1999-10-05
JP2571344B2 (ja) 1997-01-16
CA2129990A1 (en) 1993-09-02
NO943133D0 (no) 1994-08-24
CA2129990C (en) 2006-01-10
DK0628033T3 (da) 2003-11-10
CN1051079C (zh) 2000-04-05

Similar Documents

Publication Publication Date Title
DE69333108D1 (de) Benzodiazepin derivate verwendbar als cck-rezeptoren antagonisten
DE3889756D1 (de) Benzodiazepin-Analoge.
BG103548A (en) Vitronectine receptor antagonists
MX9703186A (es) Antagonistas del receptor del neuropeptido y de indolilo.
ATE163409T1 (de) Benz(b)azepin-2,5-dione verwendbar in der behandlung neurodegenerativer störungen
ATE205480T1 (de) 2,5-dioxo-2,5-dihydro-1h-benz(b)azepine als nmda rezeptor antagonisten
DE69419157D1 (de) Tetrahydro-1h-benzazepinone und hexahydro azepinone als selektive cholecystokinin-b rezeptor antagonisten
FI960223A (fi) 1,5-bentsodiatsepiinijohdannaisia, jotka ovat käyttökelpoisia CCK- tai gastriiniantagonisteina
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
ATE169002T1 (de) Polyamidsäure-derivate mit antigastrin wirkung, ihre herstellung und ihre verwendung als arzneimittel
DE69332019D1 (de) 4-oxo-und 4h-imidazo(5,1-c)(1,4)benzoxazine nützlich als benzodiazepinrezeptor-bindemittel.
DE69411909D1 (de) 3-phenylureido-1,5-benzodiazepin-dione verwendbar als gastrin- oder cck antagonisten
GR3027609T3 (en) Carbamate derivatives and their use in medicine.
TR199800488T1 (xx) Diskinezi i�in 5-HT3 resept�r antagonistleri.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP

Owner name: FERRING RESEARCH LTD., FELTHAM, GB

8339 Ceased/non-payment of the annual fee